Original Research

Published on 19 Apr 2023

Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach

in Pharmacology of Infectious Diseases

Shopnil Akash
Arafat Hossain
Nobendu Mukerjee
Md. Moklesur Rahman Sarker
Mohammad Firoz Khan
Md. Jamal Hossain
Mohammad A. Rashid
Ajoy Kumer
Arabinda Ghosh
Darwin A. León-Figueroa

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1140494

3,788 views
4 citations

Original Research

Published on 17 Apr 2023

Hypericum japonicum extract inhibited porcine epidemic diarrhea virus in vitro and in vivo

in Pharmacology of Infectious Diseases

Hongyu Rao
Weiwei Su
Xiaoli Zhang
Yonggang Wang
Tao Li
Jinliang Li
Xuan Zeng
Peibo Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1112610

2,536 views
4 citations

Original Research

Published on 13 Apr 2023

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

in Pharmacology of Infectious Diseases

Laurynas Mockeliunas
Alan Faraj
Rob C. van Wijk
Caryn M. Upton
Gerben van den Hoogen
Andreas H. Diacon
Ulrika S. H. Simonsson

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1150243

3,171 views
2 citations

Review

Published on 12 Apr 2023

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now

in Pharmacology of Infectious Diseases

Mona A. Mohammed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1111329

7,263 views
15 citations

Editorial

Published on 11 Apr 2023

Editorial: Novel antimicrobials and antibiotics resistance modulating agents from natural products: Turning promises into Triumphs

in Pharmacology of Infectious Diseases

Nada M. Mostafa
Muhammad Ayaz
Mohamed El-Shazly
Abdel Nasser B. Singab

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184071

1,130 views
2 citations

Original Research

Published on 30 Mar 2023

Effect of traditional Chinese medicine monomers interfering with quorum-sensing on virulence factors of extensively drug-resistant Acinetobacter baumannii

in Pharmacology of Infectious Diseases

Li Zeng
Fei Lin
Baodong Ling

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1135180

2,101 views
6 citations

Brief Research Report

Published on 29 Mar 2023

Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis

in Pharmacology of Infectious Diseases

Wisse van Os
Beatrix Wulkersdorfer
Sabine Eberl
Zoe Oesterreicher
Philipp Schwabl
Thomas Reiberger
Rafael Paternostro
Maria Weber
Birgit Willinger
Markus Zeitlinger

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1124821

2,384 views
2 citations

Original Research

Published on 27 Mar 2023

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients

in Pharmacology of Infectious Diseases

Ge Shao
Ziwei Bao
Lina Davies Forsman
Jakob Paues
Jim Werngren
Katarina Niward
Thomas Schön
Judith Bruchfeld
Jan-Willem Alffenaar
Yi Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1022090

2,608 views
3 citations

Original Research

Published on 24 Mar 2023

Risk factors associated with inappropriate empirical antimicrobial treatment in bloodstream infections. A cohort study

in Pharmacology of Infectious Diseases

Beatriz Dietl
Lucía Boix-Palop
Laura Gisbert
Aina Mateu
Gemma Garreta
Mariona Xercavins
Cristina Badía
María López-Sánchez
Josefa Pérez
Esther Calbo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1132530

2,451 views
4 citations

Systematic Review

Published on 24 Mar 2023

Dose optimization of vancomycin in obese patients: A systematic review

in Pharmacology of Infectious Diseases

Mahmoud E. Elrggal
Abdul Haseeb
Manal AlGethamy
Umar Ahsan
Zikria Saleem
Areej Sultan Althaqafi
Sattam Saad Alshuail
Zohair Ahmad Alsiddiqi
Muhammad Shahid Iqbal
Albaraa Faraj Alzahrani

Frontiers in Pharmacology

doi 10.3389/fphar.2023.965284

8,274 views
2 citations

Systematic Review

Published on 20 Mar 2023

Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis

in Pharmacology of Infectious Diseases

Hossein Nateghizad
Rojina Sajadi
Ali Shivaee
Omid Shirazi
Mohadeseh Sharifian
Danyal Abbasi Tadi
Kumarss Amini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1027277

5,658 views
3 citations

Editorial

Published on 16 Mar 2023

Editorial: Advances in antimicrobial therapy and combating resistance

in Pharmacology of Infectious Diseases

Islam M. Ghazi
Wasim S. El Nekidy

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170289

873 views

Original Research

Published on 15 Mar 2023

Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience

in Pharmacology of Infectious Diseases

Dragana Sokolović
Dragana Drakul
Vesna Vujić‐Aleksić
Bojan Joksimović
Siniša Marić
Lana Nežić

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1067973

3,947 views
8 citations

Original Research

Published on 14 Mar 2023

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development

in Pharmacology of Infectious Diseases

Rami Ayoun Alsoud
Robin J. Svensson
Elin M. Svensson
Stephen H. Gillespie
Martin J. Boeree
Andreas H. Diacon
Rodney Dawson
Rob E. Aarnoutse
Ulrika S. H. Simonsson

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1067295

2,860 views
2 citations

Original Research

Published on 13 Mar 2023

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis

in Pharmacology of Infectious Diseases

Junzhen Wu
Xinyi Yang
Jufang Wu
Jingjing Wang
Hailan Wu
Yu Wang
Hong Yuan
Huahui Yang
Hailin Wang
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1135007

2,183 views
3 citations

Review

Published on 09 Mar 2023

An update on SARS-CoV-2 immunization and future directions

in Pharmacology of Infectious Diseases

Rashmi Rana
Ravi Kant
Tanya Kumra
Sneha Gupta
Devinder Singh Rana
Nirmal Kumar Ganguly

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1125305

3,830 views
5 citations

Navigation group

Articles

Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach

Hypericum japonicum extract inhibited porcine epidemic diarrhea virus in vitro and in vivo

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now

Editorial: Novel antimicrobials and antibiotics resistance modulating agents from natural products: Turning promises into Triumphs

Effect of traditional Chinese medicine monomers interfering with quorum-sensing on virulence factors of extensively drug-resistant Acinetobacter baumannii

Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients

Risk factors associated with inappropriate empirical antimicrobial treatment in bloodstream infections. A cohort study

Dose optimization of vancomycin in obese patients: A systematic review

Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis

Editorial: Advances in antimicrobial therapy and combating resistance

Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience

Combined quantitative tuberculosis biomarker model for time-to-positivity and colony forming unit to support tuberculosis drug development

Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis

An update on SARS-CoV-2 immunization and future directions